NWL vs PPCB · rev $7.58B vs P/E 0.0, $3.9M cap
Newell Brands Inc (NWL) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Newell Brands Inc (NWL) is a household & personal products company listed on NASDAQ.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported NWL revenue for 2024-12-31 was $7.58B. Net income was -$216.0M. Revenue was down 6.8% from 2023-12-31 to 2024-12-31. NWL currently screens at market cap $2.11B.
PPCB does not have a complete income-statement cache yet.
NWL currently screens at market cap $2.11B. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the NWL and PPCB stock pages for the full models.
Not investment advice.